Naoto Yoshino

4PUBLICATIONS
4CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Surface properties of condensed matterAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 25, 2023
Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines.

Naoto Yoshino, Takuya Yokoyama, Hironori Sakai

|Feb 11, 2023
Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor.

Masahiro Kagabu, Naoto Yoshino, Kazuyuki Murakami

|Jun 24, 2018
Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides.

Naoto Yoshino, Ryosuke Takeshita, Hanae Kawamura

|Nov 07, 2017
Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice.

Naoto Yoshino, Ryosuke Takeshita, Hanae Kawamura

Pageof 1